Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis
D Aliseda, J Arredondo… - British Journal of …, 2024 - academic.oup.com
Background Neoadjuvant chemotherapy is increasingly used to treat locally advanced (T3–
4 Nx–2 M0) colon cancer due to its potential advantages over the standard approach of …
4 Nx–2 M0) colon cancer due to its potential advantages over the standard approach of …
[HTML][HTML] Robot-assisted fluorescent sentinel lymph node identification in early-stage colon cancer
DJ Sikkenk, AJ Sterkenburg, TA Burghgraef, H Akol… - Surgical …, 2023 - Springer
Background Patients with cT1-2 colon cancer (CC) have a 10–20% risk of lymph node
metastases. Sentinel lymph node identification (SLNi) could improve staging and reduce …
metastases. Sentinel lymph node identification (SLNi) could improve staging and reduce …
[HTML][HTML] Improving surgery and prognostication in right-sided colon cancer
KB Lygre - 2024 - bora.uib.no
Background The incidence of colon cancer is high in Norway. Surgery is the mainstay in the
treatment of colon cancer but has not undergone the same improvements as rectal cancer …
treatment of colon cancer but has not undergone the same improvements as rectal cancer …